Tomocube, Inc. (KOSDAQ:475960)

Market Cap	335.33B
Revenue (ttm)	5.38B
Net Income (ttm)	-8.66B
Shares Out	13.25M
EPS (ttm)	-776.52
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	149,310
Average Volume	114,871
Open	25,450
Previous Close	25,300
Day's Range	25,050 - 26,450
52-Week Range	9,930 - 32,500
Beta	n/a
RSI	55.69
Earnings Date	Aug 14, 2025

About The Aaron's Company

Tomocube, Inc. engages in the manufacture and sale of optical devices and medical equipment. Its holotomography (HT) products include HT-X1 for live-cell imaging and analysis; and HT-2H for 3D live cell imaging. The company also offers TomoAnalysis, a 3D image visualization and analysis software. In addition, it provides accessories, such as HT-ready 96 well plates; TomoDish that is designed to accommodate both adherent and suspension cells; TomoChamber, a stage-top incubator designed for long-term live cell imaging; TomoPlate, an active vibrat...

• Industry: Laboratory Apparatus and Furniture
• Founded: 2015
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 475960

Financial Performance

In 2024, Tomocube's revenue was 5.94 billion, an increase of 58.48% compared to the previous year's 3.75 billion. Losses were -8.30 billion, -64.75% less than in 2023.

Financial numbers in CAD